Oxidative stress in breast cancer after chemotherapy
- PMID: 37701507
- PMCID: PMC10492917
- DOI: 10.6026/973206300181141
Oxidative stress in breast cancer after chemotherapy
Abstract
It is of interest to evaluate the influence of breast cancer on oxidative stress, liver function tests, renal biomarkers, action of doxorubicin, cyclophosphamide and paclitaxel (AC-T) in the treatment and mechanism over altering the measured markers in breast cancer. Sixty histopathological confirmed cases of female patients suffering with breast carcinoma from the Department of Oncology at Omega Cancer Hospital, Visakhapatnam were included in the study. The investigation was performed in 3 groups: a control group containing 30 healthy females of similar age, 30 breast cancer patients without treatment and 30 patients receiving treatment with anticancer combination drugs AC-T. The venous blood samples from both controls and patients were measured for total antioxidant status (TAS), nitric oxide (NO), malondialdehyde, alanine aminotransferase, aspartate aminotransferase, and blood urea, serum creatinine. One-way ANOVA and Tukey-Kramer multiple comparisons post-test were applied as statistical analysis tools through SPPS software version 20.0. P<0.05 was regarded as significant. According to the findings, higher stages of breast cancer were linked to considerable increase in oxidative stress markers during AC-T treatment. The findings of the study revealed that oxidative stress is linked to breast cancer, and that chemotherapy exacerbates this oxidative stress, causing damage to a variety of cellular _targets. Monitoring serum oxidative stress markers may aid in the evaluation of chemotherapy effects in breast cancer patients. According to our findings, AC-T chemotherapy will elevate malondialdehyde, a lipid peroxidation marker, and lowers the total antioxidant status.
Keywords: Breast cancer; chemotherapy; malondialdehyde; oxidative stress; total antioxidant status.
© 2022 Biomedical Informatics.
Conflict of interest statement
The authors declared no conflict of interest.
Similar articles
-
Impact of breast cancer and combination chemotherapy on oxidative stress, hepatic and cardiac markers.J Breast Cancer. 2012 Sep;15(3):306-12. doi: 10.4048/jbc.2012.15.3.306. Epub 2012 Sep 28. J Breast Cancer. 2012. PMID: 23091543 Free PMC article.
-
Three cycles of AC chemotherapy regimen increased oxidative stress in breast cancer patients: A clinical hint.Caspian J Intern Med. 2017 Fall;8(4):264-268. doi: 10.22088/cjim.8.4.264. Caspian J Intern Med. 2017. PMID: 29201316 Free PMC article.
-
Chemotherapy modulates the biological activity of breast cancer patients plasma: the protective properties of black chokeberry extract.Food Chem Toxicol. 2013 Mar;53:126-32. doi: 10.1016/j.fct.2012.11.042. Epub 2012 Dec 5. Food Chem Toxicol. 2013. PMID: 23220617
-
Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy.Breast Cancer Res Treat. 2012 May;133(1):89-97. doi: 10.1007/s10549-011-1693-x. Epub 2011 Aug 3. Breast Cancer Res Treat. 2012. PMID: 21811816
-
Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.JAMA Oncol. 2015 Dec;1(9):1311-8. doi: 10.1001/jamaoncol.2015.3062. JAMA Oncol. 2015. PMID: 26402167 Free PMC article. Review.
Cited by
-
Construction of a novel mitochondrial oxidative stress-related genes prognostic system and molecular subtype characterization for breast cancer.Discov Oncol. 2024 Nov 8;15(1):631. doi: 10.1007/s12672-024-01522-y. Discov Oncol. 2024. PMID: 39514138 Free PMC article.
References
LinkOut - more resources
Full Text Sources